10.1016/j.neuint.2019.104624 58 LiuQ.CaiB.ZhuL.XinX.WangX.AnZ.et al (2020b)
In our clinic, we treat GLP-1 nausea as a problem to address actively, not as an inevitable cost of the medication
Tirzepatide achieved up to 22.5% in its 72-week Phase 3 SURMOUNT-1 trial
If vomiting is severe or persists, there is blood in the vomit, or intense stomach pain, seek immediate medical attention
Potential Benefits Under Clinical Study While research is ongoing, clinical trials for Retatrutide have highlighted several areas of potential improvement in cardiometabolic health : Meaningful Weight Reduction: Studies have explored significant percentages of body weight loss over extended periods
As a result, companies need to focus on building recognition with doctors while simultaneously pursuing brand promotion strategies